COVID-19 is the challenge of our time
From smallpox to polio, the biggest infectious disease challenges in recent human history have been overcome by collaborative, outside the box scientific research. We are honored to see immunologists across the world using our single cell and spatial characterization technologies to gain a holistic understanding of COVID-19, its pathophysiological signatures, and the cell-mediated immune response.
Global Immunology Virtual Symposium | May 24–28, 2021
Connect with a global community of immunologists and hear from leading researchers as they discuss their latest breakthroughs—from transplantation to infectious disease.
Solve Infectious Disease with Single Cell and Spatial Multiomics
Multiomic single cell and spatial technologies have emerged as crucial infectious disease tools, enabling a holistic understanding of COVID-19, its effects on the body, and how to approach possible treatments. Already, scientists have used 10x Genomics solutions to resolve the tissue and cellular specificity of SARS-CoV-2 infection, uncover the relationships between immune responses and COVID-19 severity, and rapidly identify novel antibody prophylaxis reagents.
Explore the following articles to learn how multiomic technology is driving the next cycle of innovation for infectious disease research, uncovering deep insights into virology and human immunity, and how it is already being deployed in the fight against COVID-19.
Researchers develop potential coronavirus antibody therapiesRead this article from VUMC Reporter to learn how a team of researchers from Vanderbilt University are using 10x Genomics solutions to rapidly identify antiviral therapeutic antibodies from the serum of COVID-19 patients.
Single cell atlases advance COVID-19 immunopathology understandingWe spoke with Dr. Naftali Kaminski of the Yale School of Medicine about his work developing an idiopathic pulmonary fibrosis cell atlas and a collaborative study investigating COVID immunopathology. Learn how these studies leveraged scRNA-seq to understand the cellular and molecular basis of chronic lung disease.
The path to a vaccine: research storiesExplore this summary of innovative COVID-19 research that helped us understand the virus and the host immune response to see how far we’ve come on the path to a vaccine.
Mapping COVID-19 Discoveries
From individual laboratories and institutions to global research consortiums, scientists everywhere are bringing their expertise and the most cutting-edge technology to bear on the COVID-19 problem. We are inspired and amazed to see our technology advancing these global efforts, including a Proteona-led collaboration to identify broadly neutralizing antibodies for immunocompromised patients, the Human Cell Atlas’ COVID-19 Cell Atlas, and the Human Vaccines Project.
Take a look at this global map to see where scientists are using single cell and spatial technology to advance our knowledge of COVID-19.
Find tools to decipher the complexity of infectious disease
Connect your infectious disease research questions with tools that will help you find the answers you need. Explore crucial applications of our single cell and spatial technology for infectious disease research.
Redefine Immunology with Multiomic Single Cell and Spatial Characterization
Uncover the layers of immune cell complexity with single cell and spatial tools from 10x Genomics. Find publications, application notes, and seminars to help you get started.
Multiomic Cytometry ExperienceEnter this interactive technology exhibit to compare cytometry techniques for your studies of the immune response. Explore the immune response to infectious disease with multiomic resolution.
WebinarsSee how spatial gene expression profiling can provide a powerful complement to traditional histopathology, enabling a detailed view of the tumor microenvironment architecture.
Immunology Multiomics 101From profiling immune cells in disease to understanding T-cell exhaustion, find guidance for your immunology research with this one-stop-shop resource for multiomic single cell experimental planning.